Skip to main content

Advertisement

SpringerLink
Log in

Biochemical and genetic studies on cardiometabolic syndrome

  • Original Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Cardiometabolic syndrome is one of the major public health issues of this century which describes a cluster of clinical characteristics. Seventy two patients with coronary artery disease (CAD) and cardiometabolic syndrome and forty healthy age and sex matched normal controls were selected for this study. Detailed clinical epidemiological and anthropometric characteristics were noted. Lipid profile and Cytokinesis-block micronuclei (CBMN) assay using cytochalasin B were carried out in all the subjects. Serum total cholesterol, triglyceride and LDL-cholesterol was significantly higher and HDL cholesterol was significantly lower in patients compared to their normal counter-parts (P<0.05). CBMN frequency of the patients was significantly higher at all ages compared to their normal counter parts (P<0.05). Various risk factors like diabetes, hypertension, dyslipidemia, abdominal obesity, smoking and alcoholism were found influenced the CBMN frequency; but the changes were not significant. From this study it can be concluded that DNA damage was found to be higher in patients with cardiometabolic syndrome which may be attributed to the generation of free radicals associated with alcohol consumption, tobacco use, dyslipidemia and glucose intolerance and the accumulation of free radicals with increase in age.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112:2735–2752.

    Article  PubMed  Google Scholar 

  2. Govindarajan G, Whaley-Connell A, Mugo M, Stump C, Sowers JR. The cardiometabolic syndrome as a cardiovascular risk factor. Am J Med Sci 2005; 330(6): 311–318

    Article  PubMed  Google Scholar 

  3. Pandey S, Baral N, Majhi S, Acharya P, Karki P, Shrestha S, et al. Prevalence of the metabolic syndrome in acute myocardial infarction and its impact on hospital outcomes. Int J Diab Dev Ctries 2009; 29: 52–55

    Article  CAS  Google Scholar 

  4. Frisard MI, Rood JC, Fang X, Su J, Welsh DA, Jazwinski SM, Ravussin E Metabolic syndrome and risk factors for cardiovascular disease: are nonagenarians protected? Age (Dordr) 2009; 31(1): 67–75.

    Article  CAS  Google Scholar 

  5. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365:1415–1428.

    Article  CAS  PubMed  Google Scholar 

  6. Andreassi MG. Metabolic syndrome, diabetes and atherosclerosis: influence of gene-environment interaction. Mutat Res 2009; 667(1–2):35–43.

    CAS  PubMed  Google Scholar 

  7. Botto N, Mssetti S, Petrozzi L. Elevated levels of oxidative DNA damage in patients with coronary artery disease. Coron Artery Dis 2002; 13:269–274.

    Article  PubMed  Google Scholar 

  8. Andreassi MG. Coronary atherosclerosis and somatic mutations: an overview of the contributive factors for oxidative DNA damage. Mutat Res 2003; 543: 67–86.

    Article  CAS  PubMed  Google Scholar 

  9. Demirbag R, Yilmaz R, Gur M, Celik H, Guzel S, Selek S et al. DNA damage in metabolic syndrome and its association with antioxidative and oxidative measurements. Int J Clin Pract 2006; 60: 1187–1193.

    Article  CAS  PubMed  Google Scholar 

  10. Rifai N, Bachorik PS, Albers JJ. Lipids,lipoprotein and apolipoprotein. In Burtis CA, Ashwood R., editors. Tietz textbook of clinical chemistry 3rd ed. Philadelphia. W.B. Saunders company. 1999: 806–861.

    Google Scholar 

  11. Mc Gowan MW, Artiss JD, Standbergh DR, Zark B. A peroxidase coupled method for the colorimeteric determination of serum triglycerides. Clin Chem 1983; 29(3): 538–542.

    CAS  Google Scholar 

  12. Sugiuchi H, Uji Y, Okabe H, Irie T, Uekama K, Kayahara N, et al. Direct measurement of High-Density Lipoprotein Cholesterol in serum with polyethylene glycol-modified enzymes and sulphated alpha-cyclodextrin. Clin Chem 1995; 41:717–723.

    CAS  PubMed  Google Scholar 

  13. Armstrong V, Seidel D. Evaluation of a commercial kit for the determination of LDL-cholesterol in serum based on precipitation of LDL with dextran sulphate. Arztl Lab 1985; 31: 325–330.

    Google Scholar 

  14. Moorhead PS, Nowell PC, Mellman WJ, Battips DM, Hungerford DA. Chromosome preparations of leukocytes cultured from human peripheral blood. Exp Cell Res 1960; 20: 613–616.

    Article  CAS  PubMed  Google Scholar 

  15. Fenech M. The cytokinesis-block micronucleus technique and its application to genotoxicity studies in human populations. Environmental Health Perspectives 1993; 101(3):101–107.

    Article  CAS  PubMed  Google Scholar 

  16. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome in U.S. adults. JAMA 2002; 287: 356–359.

    Article  PubMed  Google Scholar 

  17. Deepa M, Farooq S, Datta M, Deepa R, Mohan V. Prevalence of metabolic syndrome using WHO, ATP III, and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev 2007; 23: 127–134.

    Article  CAS  PubMed  Google Scholar 

  18. Abbott RD, Curb JD, Rodriguez BL, Masaki KH, Yano K, Schatz IJ, et al. Age-related changes in risk factor effects on the incidence of coronary heart disease. Ann Epidemiol 2002; 12: 173–181.

    Article  PubMed  Google Scholar 

  19. Ghosh J, Mishra T K, Rao Y N, Aggarwal S K. Oxidised LDL, HDL cholesterol, LDL cholesterol levels in patients of coronary artery disease. Ind J Clin Biochem 2006; 21: 181–184.

    Article  CAS  Google Scholar 

  20. Lahdenpera S, Syvanne M, Kahri J, Taskinen MR. Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides. Diabetologia 1996; 39(4):453–461.

    Article  CAS  PubMed  Google Scholar 

  21. Ishizaka N, Ishizaka Y, Toda E, Hashimoto H, Nagai R, Yamakado M. Association between cigarette smoking, metabolic syndrome, and carotid arteriosclerosis in Japanese individuals. Atherosclerosis 2005; 181: 381–388.

    Article  CAS  PubMed  Google Scholar 

  22. Nakanishi N, Takatorige T, Suzuki K. Cigarette smoking and the risk of the metabolic syndrome in middle-aged Japanese male office workers. Ind Health 2005; 43: 295–301.

    Article  PubMed  Google Scholar 

  23. Ramachandran A, Snehalatha C, Satyavani K, Weiss R, Dziura J, Burgert TS. Metabolic syndrome in urban Asian Indian adults: a population study using modified ATP III criteria. Diabetes Res Clin Pract 2003; 60: 199–204.

    Article  CAS  PubMed  Google Scholar 

  24. Balkau B, Picard P, Vol S, Fezeu L and Eschwège E. Consequences of Change in Waist Circumference.Diabetes Care 2007; 30(7): 1901–1903.

    Article  CAS  PubMed  Google Scholar 

  25. Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB. Comparison of abdominal adiposity and overall obesity in predicing risk of Type 2 diabetes among man. Am J Clin Nutr 2005;81:555–563.

    CAS  PubMed  Google Scholar 

  26. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990; 263: 2893–2898.

    Article  CAS  PubMed  Google Scholar 

  27. McPhillips JB, Barrett-Connor E, Wingard DL. Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults. Am J Epidemiol 1990; 131: 443–453.

    CAS  PubMed  Google Scholar 

  28. Mykkanen L, Kuusisto J, Pyorala K, Laakso M. Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in early subjects. Diabetologia 1993; 36: 553–559.

    Article  CAS  PubMed  Google Scholar 

  29. Zimmet PZ, Alberti KGMM. The changing face of macrovascular disease in non-insulin-dependent diabetes mellitus: an epidemic in progress. Lancet 1997;350(1):1–4.

    Article  Google Scholar 

  30. Mahadik SR, Deo SS, Mehtalia SD. Increased prevalence of metabolic syndrome in non-obese Asian Indian-an urban-rural comparison. Metab Syndr Relat Disord 2007; 5(2): 142–152

    Article  CAS  PubMed  Google Scholar 

  31. Fan AZ, Russell M, Dorn J, Freudenheim JL, Nochajski T, Hovey K, et al. Lifetime alcohol drinking pattern is related to the prevalence of metabolic syndrome. The Western New York Health Study (WNYHS). Eur J Epidemiol 2006; 21:129–138.

    Article  CAS  PubMed  Google Scholar 

  32. Wei-ju L, Hao X, Kai S, Xiao-dong S, Yi-bo W, Yi-song Z, et al Cardiovascular risk and prevalence of metabolic syndrome by differing criteria. Chin Med J 2008; 121: 1532–1536.

    Google Scholar 

  33. Nishtha J, Imrana N, Jamal A. Evaluation of DNA damage and metabolic syndrome parameters in diabetic rabbits supplemented with antioxidants. Fundamental Clin Pharmacol 2009; 23: 197–205

    Article  Google Scholar 

  34. Satoh M, Ishikawa Y, Takahashi Y, Itoh T, Minami Y, Nakamura M Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease. Atherosclerosis 2008; 198(2): 347–353.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, Pushpagiri Institute of Medical Sciences and Research Centre, Thiruvalla, Kerala, 689 101, India

    A. Supriya Simon

  2. Genetika, Centre for Advanced Genetic Studies, Thiruvananthapuram, 695 024, India

    D. Dinesh Roy

  3. Govt. General Hospital, Thiruvananthapuram, India

    V. Jayapal

  4. School of Health Sciences, Kannur University, Kerala, India

    T. Vijayakumar

Authors
  1. A. Supriya Simon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Dinesh Roy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. Jayapal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. Vijayakumar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Supriya Simon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Supriya Simon, A., Dinesh Roy, D., Jayapal, V. et al. Biochemical and genetic studies on cardiometabolic syndrome. Indian J Clin Biochem 25, 164–168 (2010). https://doi.org/10.1007/s12291-010-0030-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-010-0030-1

Key Words

Search

Navigation